|
Via Industria 24 6710 Biasca |
| T.: +41 91 873 94 00 |
| F.: +41 91 873 01 11 |
| https://www.hashealthcare.com/ |
| info@hashealthcare.com |
        
|
-
Main activities Co-development ● Drug Substance CMO ● Other CMO Activities ● -
Drug stages Phase I - Phase III ● Registration ● Market ● Generic ● Life cycle management ● -
Therapeutic areas Cancer supportive therapy ● CNS ● Dermatology ● Gastrointestinal ● Gynaecology ● Oncology ● Ophtalmology ● Respiratory ● Other ● -
Markets CH ● EU Top 5 ● Rest of Europe ● USA and Canada ● LATAM ● Japan ● -
Drug substance type APIs (1-10kgs/batch) ● APIs (20-200kgs/batch) ● APIs (>200kgs/batch) ● HPAI 10-100g/batch ● HPAI 0.2-5kgs/batch ● HPAI 6-20kgs/batch ● HPAI >20kgs/batch ● HPAI Cat. 3 safebridge ● Cytotoxics ● -
Other CMO activities Micronization ●
Linkedin